Most U.S. employers don't cover weight loss drugs — and fewer plan on doing so
Less than a fifth of large employers in the U.S. include coverage for the popular but pricey weight loss drugs Wegovy and Zepbound, a KFF survey finds.

What's Your Reaction?






